The UNION chemistry platform has broad applicability across a wide number of diseases. Due to the unique and novel mode of action of the UNION compounds several diseases can be addressed. As information about the complex and important interactions of the microbiome and the immune system is accumulating the potential therapeutic strategies enabled by UNION's chemistry platform is expanding.

Using a combination of known and novel molecules UNION is advancing a diversified pipeline comprised of both molecules that can be rapidly developed through approval as well as novel chemical entities discovered from the active medicinal chemistry program of UNION.

UNION has entered into collaborations with some of the world’s leading academic groups and institutions to elucidate the full potential of the chemical class in diverse disease areas.

We welcome collaboration with academia, biotech and pharma companies to further exploit the opportunities of the chemical class.